Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Wade

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Investigative Urology|January 1, 1981
A noninvasive technique for monitoring changes in canine prostatic size in vivoD R Wade, J C Pirmann, M L Winter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone ratR A Browning, D R Wade, M Marcinczyk, et al.
Journal of Medicinal Chemistry|February 1, 1978
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agentsJ M Kokosa, J E Sinsheimer, D R Wade, et al.
The Prostate|June 1, 1995
Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5 alpha-dihydrotestosterone and 17 beta-estradiolM L Winter, M C Bosland, D R Wade, et al.
Journal of Medicinal Chemistry|December 1, 1978
alpha-(2-Pyridine)benzyl aryl ketones as potential hypocholesteremic agentsL E Hewitt, D R Wade, J E Sinsheimer, et al.
Journal of Medicinal Chemistry|May 11, 1976
Metabolic formation and synthesis of 1-(3-chlorophenyl)-2(4-hydroxyphenyl)-1-methyl-2(2 pyridine)ethanol. A potential hypocholesteremic agentJ E Sinsheimer, E Van den Eeckhout, L E Hewitt, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Investigative Urology|January 1, 1981
A noninvasive technique for monitoring changes in canine prostatic size in vivoD R Wade, J C Pirmann, M L Winter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone ratR A Browning, D R Wade, M Marcinczyk, et al.
Journal of Medicinal Chemistry|February 1, 1978
Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agentsJ M Kokosa, J E Sinsheimer, D R Wade, et al.
The Prostate|June 1, 1995
Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5 alpha-dihydrotestosterone and 17 beta-estradiolM L Winter, M C Bosland, D R Wade, et al.
Journal of Medicinal Chemistry|December 1, 1978
alpha-(2-Pyridine)benzyl aryl ketones as potential hypocholesteremic agentsL E Hewitt, D R Wade, J E Sinsheimer, et al.
Journal of Medicinal Chemistry|May 11, 1976
Metabolic formation and synthesis of 1-(3-chlorophenyl)-2(4-hydroxyphenyl)-1-methyl-2(2 pyridine)ethanol. A potential hypocholesteremic agentJ E Sinsheimer, E Van den Eeckhout, L E Hewitt, et al.
Pageof 2